Free Trial

15,000 Shares in Roche Holding AG $RHHBY Bought by Corient IA LLC

Roche logo with Medical background

Key Points

  • Corient IA LLC has acquired a new stake in Roche Holding AG, purchasing 15,000 shares valued at approximately $616,000 during the first quarter.
  • Multiple institutional investors, including Fulton Bank N.A. and PNC Financial Services Group Inc., have recently adjusted their holdings in Roche, indicating increased interest in the stock.
  • Roche's stock currently has an average rating of "Moderate Buy" according to analyst reports, following recent downgrades from HSBC from a "buy" to a "hold" rating.
  • MarketBeat previews top five stocks to own in October.

Corient IA LLC purchased a new position in Roche Holding AG (OTCMKTS:RHHBY - Free Report) during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 15,000 shares of the company's stock, valued at approximately $616,000.

A number of other institutional investors and hedge funds have also modified their holdings of the company. Fulton Bank N.A. grew its holdings in shares of Roche by 2.6% in the 1st quarter. Fulton Bank N.A. now owns 12,620 shares of the company's stock worth $518,000 after acquiring an additional 314 shares during the period. PNC Financial Services Group Inc. grew its holdings in shares of Roche by 2.0% in the 1st quarter. PNC Financial Services Group Inc. now owns 16,234 shares of the company's stock worth $668,000 after acquiring an additional 323 shares during the period. Confluence Investment Management LLC grew its holdings in shares of Roche by 3.6% in the 1st quarter. Confluence Investment Management LLC now owns 14,491 shares of the company's stock worth $596,000 after acquiring an additional 510 shares during the period. Accent Capital Management LLC acquired a new stake in shares of Roche in the 1st quarter worth approximately $35,000. Finally, North Star Asset Management Inc. grew its holdings in shares of Roche by 7.8% in the 1st quarter. North Star Asset Management Inc. now owns 17,305 shares of the company's stock worth $712,000 after acquiring an additional 1,255 shares during the period.

Roche Stock Performance

Shares of Roche stock traded up $0.33 during trading hours on Friday, reaching $40.78. 812,277 shares of the company's stock were exchanged, compared to its average volume of 2,288,061. Roche Holding AG has a 52-week low of $34.1030 and a 52-week high of $44.31. The company has a fifty day moving average of $40.00 and a 200-day moving average of $40.27. The company has a current ratio of 1.48, a quick ratio of 1.20 and a debt-to-equity ratio of 0.85.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on RHHBY shares. Hsbc Global Res cut Roche from a "strong-buy" rating to a "hold" rating in a report on Monday, April 28th. HSBC cut Roche from a "buy" rating to a "hold" rating in a report on Monday, April 28th. Two analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Roche presently has an average rating of "Moderate Buy".

Get Our Latest Analysis on RHHBY

Roche Profile

(Free Report)

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.

Recommended Stories

Institutional Ownership by Quarter for Roche (OTCMKTS:RHHBY)

Should You Invest $1,000 in Roche Right Now?

Before you consider Roche, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Roche wasn't on the list.

While Roche currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report
Like this article? Share it with a colleague.